Novanta Inc (NOVT)

Industry Scientific & Technical Instruments
This stock can be held in an Investment ISA and an Investment Account
Sell

$49.71

Buy

$198.30

arrow-down$-0.50 (-0.40%)

Prices updated at 30 May 2025, 21:21 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Novanta Inc,designs, develops, manufactures and sells precision photonic and motion control components and subsystems to original equipment manufacturers in the medical, industrial, electronics and scientific markets.
NASDAQ
arrow-down-0.32%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Technology
Industry
Scientific & Technical Instruments
Chairman
Mr. Matthijs Glastra
CEO
Mr. Matthijs Glastra
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
3,000
Head office
125 Middlesex Turnpike
Bedford
United States
01730
mobile
+1 781 266-5700
letter
-
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Mr. Lonny J. Carpenter
Lead Independent Director
0.12m
Mr. Frank Anders Wilson
Independent Director
0.10m
Mr. Robert J. Buckley
Chief Financial Officer
0.55m
Dr. Darlene J.S. Solomon, PhD
Independent Director
0.08m
Mr. Thomas N. Secor
Independent Director
0.08m
Mr. Matthijs Glastra
Chairman of the Board and Chief Executive Officer
0.83m
Ms. Maxine Lum Mauricio
Independent Director
0.08m
Ms. Barbara B. Hulit
Independent Director
0.08m
Ms. Mary Katherine Ladone
Independent Director
0.03m
Ms. Michele Davis Welsh
General Counsel and Corporate Secretary
0.38m
Mr. R. Matthew Johnson
Independent Director
0.04m
Mr. John Joseph Burke, II
Chief Accounting Officer
-
Mr. John Lesica
Co-Chief Operating Officer, Medical Solutions
-
Mr. Chuck Ravetto
Co-Chief Operating Officer, Automation Enabling Technologies
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
BlackRock Inc4,528,441
Vanguard Group Inc4,092,650
BlackRock Fund Advisors2,724,700
T Rowe Price Associates, Inc2,065,133
T. Rowe Price Associates, Inc.1,831,820

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
11 Dec 2024-
11 Dec 2024-
05 Dec 2024-
05 Dec 2024-
04 Dec 2024-
04 Dec 2024-
04 Dec 2024-
02 Dec 2024-
02 Dec 2024-
02 Dec 2024-
02 Dec 2024-
02 Dec 2024-
02 Dec 2024-
02 Dec 2024-
02 Dec 2024-
02 Dec 2024-
02 Dec 2024-
02 Dec 2024-
11 Nov 2024-
11 Nov 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.